Search Results 1651-1660 of 21382 for anti-TNF drugs

  1. Clinical Trials - Precision Medicine for Obesity - Mayo Clinic Research

    Drugs & Supplements A-Z · Health Books · Healthy ... Anti-obesity phentermine-topiramate extended ... After completing testing and being randomized to the ...

  2. A Study to Investigate the Effectiveness and Safety of Pf-04965842 in Subjects Aged 12 Years and Over, With Moderate to Severe Atopic Dermatitis with the Option of Rescue Treatment in Flaring Subjects - Mayo Clinic

    Herbal medications with unknown properties or known beneficial effects for AD. Within 1 week of first dose of investigational product: Anti-platelet drugs.

  3. Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) - Mayo Clinic

    The purpose of this study is to assess the safety and efficacy of pembrolizumab (MK-3475) combination therapy in patients with metastatic castrate resistant ...

  4. A Trial to Evaluate the Effectiveness, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... treatment with more than 1 oral PAH-approved therapy or any parenteral therapy. ... anti-fibrotic drug within 4 ...

  5. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Stage 3 Liver Fibrosis - Mayo Clinic

    Participants taking anti-diabetic, anti-obesity, or anti-dyslipidemic medications must have been on stable regimens for at least 3 months (12 weeks) (6 ...

  6. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Cirrhosis - Mayo Clinic

    Participants taking anti-diabetic, anti-obesity, or anti-dyslipidemic medications must have been on stable regimens for at least 3 months (12 weeks) (6 ...

  7. Ripretinib (Oral Route) Description and Brand Names - Mayo Clinic

    Ripretinib is used to treat gastrointestinal stromal tumor (GIST) in patients who have received treatment with at least 3 other medicines (eg, imatinib).

  8. Blood and Marrow Transplant Research Program - Transplant Research Center - Mayo Clinic Research

    Develop novel treatment approaches of GVHD; Test established and state-of-the-art GVHD treatment regimens, such as anti-thymocyte globulin (ATG), post ...

  9. A Study to Evaluate Mutanome-directed Immunotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    By condition, treatment or drug ... anti-PD1, anti-PDL1 or anti-CTLA4 antibodies. ... Patients under chronic treatment with systemic corticosteroids or other ...

  10. A Study to Evaluate Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy for HER2+ Gastrointestinal Cancers - Mayo Clinic

    - For Cohorts 2A and 2B: prior anti-HER2 therapies - For Cohorts 1E, 1F, 1G, 2A: Prior therapy with an anti-PD-1, anti-PD-L1, or anti PD L2 agent or with an ...